Activities of the International Federation of Pharmaceutical Manufacturers Associations in World Health
Overview
Authors
Affiliations
The IFPMA represents 51 member associations of national pharmaceutical manufacturers throughout the world. It has developed several programs to interface and communicate with the World Health Organisation (WHO) programmes especially in regard to its activities in developing countries. Examples of collaboration with WHO are the IFPMA Training Scheme in Quality Control run jointly with the Pharmaceuticals Unit of the WHO. The IFPMA has developed a Code of Pharmaceutical Marketing Practices. It contributes to the health of both the developed and developing world through industry research, development and production of new and improved medicines. IFPMA publications provide important technical information for the global pharmaceutical industry and deal with the important issues of rational drug use in the developing world.
Stigma associated with genetic testing for rare diseases-causes and recommendations.
Baynam G, Gomez R, Jain R Front Genet. 2024; 15:1335768.
PMID: 38638122 PMC: 11024281. DOI: 10.3389/fgene.2024.1335768.
Kohler J, Wong A, Tailor L Health Hum Rights. 2022; 24(2):159-175.
PMID: 36579316 PMC: 9790937.
What makes a compliant Phase III and pre-launch patient advocacy strategy?.
Hicks N, Allan K, Thalheim C, Woods P J Mark Access Health Policy. 2016; 4.
PMID: 28003867 PMC: 5156868. DOI: 10.3402/jmahp.v4.33177.
Clinical effectiveness of split-virion versus subunit trivalent influenza vaccines in older adults.
Talbot H, Nian H, Zhu Y, Chen Q, Williams J, Griffin M Clin Infect Dis. 2015; 60(8):1170-5.
PMID: 25697739 PMC: 4447778. DOI: 10.1093/cid/civ019.
Ethical pharmaceutical promotion and communications worldwide: codes and regulations.
Francer J, Izquierdo J, Music T, Narsai K, Nikidis C, Simmonds H Philos Ethics Humanit Med. 2014; 9:7.
PMID: 24679064 PMC: 3974225. DOI: 10.1186/1747-5341-9-7.